These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22179395)

  • 1. Successful intravenous rt-PA thrombolysis for a childhood cardioembolic stroke with Emery-Dreifuss muscular dystrophy.
    Tanaka K; Uehara T; Sato K; Amano T; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 33(1):92-3. PubMed ID: 22179395
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential combination of two intravenous thrombolytics (recombinant tissue plasminogen activator/tenecteplase) in a patient with stroke and cardioembolic basilar artery occlusion.
    Smadja D; Olindo S; Saint-Vil M; Chausson N
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):68-71. PubMed ID: 19110148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation.
    Boone JD; Sherwani SS; Herborn JC; Patel KM; De Wolf AM
    Anesth Analg; 2011 Feb; 112(2):319-21. PubMed ID: 21127275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
    Matsuzaki T; Yoshino A; Sakatani K; Katayama Y
    J Stroke Cerebrovasc Dis; 2011; 20(3):269-72. PubMed ID: 20630773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with rivaroxaban.
    Ishihara H; Torii H; Imoto H; Oka F; Sadahiro H; Suzuki M
    J Stroke Cerebrovasc Dis; 2014; 23(10):e457-e459. PubMed ID: 25280819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subjects in the acute thrombolytic therapy by intravenous administration of rt-PA].
    Suzuki A; Moroi J; Nakase T; Yoshioka S; Nagata K; Sato Y; Maeda T; Sawada M; Kobayashi N; Ogura N; Izumi M
    No To Shinkei; 2006 Nov; 58(11):931-6. PubMed ID: 17133998
    [No Abstract]   [Full Text] [Related]  

  • 7. [The future perspective of acute thrombolytic therapy for acute ischemic stroke].
    Matsuki T; Toyoda K
    Nihon Rinsho; 2016 Apr; 74(4):613-20. PubMed ID: 27333749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of partial (.6 mg/kg) versus full-dose (.9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis.
    Georgiadis AL; Memon MZ; Shah QA; Vazquez G; Suri MF; Lakshminarayan K; Qureshi AI
    J Neuroimaging; 2011 Apr; 21(2):113-20. PubMed ID: 19909396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion.
    Yalcin-Cakmakli G; Akpinar E; Topcuoglu MA; Dalkara T
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):74-7. PubMed ID: 19110150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
    Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
    Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
    Naganuma M; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2011; 31(2):123-9. PubMed ID: 21088392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous thrombolysis for ischemic stroke in recurrent oligodendroglioma: a case report.
    Dafer RM; Paleologos N; Lynch D
    J Stroke Cerebrovasc Dis; 2014; 23(5):1235-8. PubMed ID: 24103669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke in a child safely treated with intravenous tissue plasminogen activator and edaravone, a free radical scavenger.
    Baba H; Sugimori H; Nanishi E; Nagata H; Lee S; Kuwashiro T; Hashizume M
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):903.e5-8. PubMed ID: 21421331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute [corrected] stroke thrombolysis: an update [corrected].
    Mehdiratta M; Caplan LR
    Prog Cardiovasc Dis; 2007; 49(6):430-8. PubMed ID: 17498523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful intravenous thrombolysis in a 14-year-old boy with ischemic stroke.
    Sampaio I; Abecasis F; Quintas S; Moreno T; Camilo C; Vieira M; Pinho e Melo T; Correia M
    Pediatr Emerg Care; 2011 Jun; 27(6):541-3. PubMed ID: 21642792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for intravenous thrombolytic therapy in acute ischemic stroke with special reference to those by the Ad Hoc Committee of the Japan Stroke Society].
    Minematsu K
    No To Shinkei; 2006 Nov; 58(11):915-21. PubMed ID: 17133996
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
    Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
    Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment results of stroke patients aged >80 years receiving intravenous rt-PA.
    Jauss M; Allendorfer J; Stolz E; Schutz HJ; Misselwitz B
    Cerebrovasc Dis; 2007; 24(2-3):305-6. PubMed ID: 17646696
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.